It has been reported that the protein levels of LAMP-1 and LAMP-2 are increased in the CSF of AD patients, together with other four lysosomal network markers (LC3, Rab3, Rab7, and EEA1) (Armstrong et al., 2014). Here, MAP1LC3A is linked to Alzheimer disease.